Furthermore, a recent paper by Shapiro et al., revealed that IgA coating to Oscillospira is linked with a delay in time to surgery in IBD patients, suggesting that IgA-coated bacteria can be clinically applied as an IBD biomarker (88). The gene discussed is CD79A; the disease is irritable bowel syndrome.